SORBITOL- sorbitol solution 
Geri-Care Pharmaceuticals, Corp

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.


gc sorbitol

Active ingredient (In each 15 mL tablespoonful)

Sorbitol 13.5 g




  • relieves occasional constipation and irregularity
  • generally produces bowel movement in 1/4 to 1 hour when used rectally
  • as a pharmaceutical aide (sweetner)
  • for other uses, as your doctor


Do not use

  • when abdominal pain, nausea, or vomiting are present
  • for more than one week unless directed by a doctor
    Ask a doctor before use if you
  • are taking mineral oil
  • have noticed a sudden change in bowel habits that lasts over 2 weeks
    Stop use and ask a doctor if

you have rectal bleeding or no bowel movement after using this product. These could be signs of a serious condition.
If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a

Poison Control Center right away.


  • do not exceed recommended dose
adults and
12 years
and over
For rectal use only. Enema dosage
is 120 mL of a 25 to 30% w/v solution
(1 part of this product with 2.3 parts water) in a single daily dose as needed, or as
directed by your doctor.
children under
12 years
Ask a doctor

Other information

  • store at room temperature 15-30C (59-86F)
  • below 59F cloudiness and thickening may occur; warming will restore clarity and fluidity without affecting product quality
  • do not freeze
  • store in original container

Inactive ingredient


Questions or comments?


package Label


sorbitol solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:57896-435
Route of AdministrationRECTAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SORBITOL (UNII: 506T60A25R) (SORBITOL - UNII:506T60A25R) SORBITOL13.5 g  in 15 mL
Inactive Ingredients
Ingredient NameStrength
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:57896-435-16473 mL in 1 BOTTLE; Type 0: Not a Combination Product01/01/2012
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33401/01/200005/01/2022
Labeler - Geri-Care Pharmaceuticals, Corp (611196254)
Registrant - GCP Laboratories (965480861)
NameAddressID/FEIBusiness Operations
GCP LABORATORIES965480861manufacture(57896-435) , pack(57896-435)

Revised: 12/2021
Geri-Care Pharmaceuticals, Corp